SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: Susan G who wrote (112694)8/28/2000 10:44:46 PM
From: kha vu  Respond to of 120523
 
SEPR: Biotek index is down today - Shares of DNA, AFFX, HGSI
and few other all went down.
SEPR traded between 104 and 107 - ended at 106 due this news:

=============
Elsewhere, shares of Sepracor (SEPR: news, msgs) gained 25/64 to stand at 106 1/8.

Marlborough, Mass.-based Sepracor said Monday that it is on track to advance its drug for insomnia into a third phase of patient testing. Typically, drugmakers must successfully complete three phases of patient testing before they can win government clearance to market a product.

cbs.marketwatch.com